New Interim Financials and MD&A docs on SEDAR

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

masila

Rank: Vice President [?]

Points: 818 [?]

Votes: 16 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

New Interim Financials and MD&A docs on SEDAR

posted on Mar 30, 2016 03:35PM

Looks like a few new documents were just published. From a quick glance, it looks like we're going to have to raise some cash quickly.